Agilent Technologies, Inc. Profile Avatar - Palmy Investing

Agilent Technologies, Inc.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromat…
Medical - Diagnostics & Research
US, Santa Clara [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
51.15 53.82 53.35 52.55 52.12 51.47 50.54 52.28 53.87 54.68 54.33 53.14 53.92 54.35 50.71
Profit Margin
-0.69 11.46 15.30 16.81 10.68 7.12 9.86 10.95 15.30 6.43 20.74 13.47 19.15 18.31 18.15
Operating Margin
1.05 10.40 16.19 16.32 14.02 11.90 12.93 14.64 18.81 18.88 18.23 15.85 21.32 23.63 19.76
EPS Growth
-104.69 2,108.93 62.22 13.36 -35.95 -29.72 -19.46 17.50 50.36 -53.77 247.96 -31.67 70.82 5.28 0.72
Return on Assets (ROA)
-0.41 6.47 11.17 10.94 6.78 4.62 5.32 5.88 8.11 3.70 11.33 7.47 11.30 11.92 11.52
Return on Equity (ROE)
-1.24 19.65 23.49 22.25 13.70 9.41 9.58 10.85 14.17 6.92 22.56 14.75 22.45 23.71 21.21
Return on Invested Capital (ROIC)
-3.71 7.43 16.18 16.40 10.04 8.00 8.13 8.45 10.48 4.87 15.33 9.99 14.67 16.74 14.49
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
40.71 38.27 24.13 22.42 25.26 25.20 22.27 24.45 23.86 21.06 25.47 24.50 25.98 26.33 25.84
Debt/Equity
123.66 116.22 50.72 45.58 51.06 51.31 40.07 45.06 41.67 39.39 50.70 48.41 51.61 52.35 47.58
Debt/EBITDA
178.57 132.23 -100.30 0.77 1.79 -23.29 -43.55 -43.74 -60.97 -36.39 83.27 74.76 70.66 90.08 67.16
Debt/Capitalization
55.29 53.75 33.65 31.31 33.80 33.91 28.61 31.06 29.41 28.26 33.64 32.62 34.04 34.36 32.24
Interest Debt per Share USD
9.21 10.91 6.54 7.08 8.23 8.48 5.20 6.08 6.49 5.84 7.90 7.89 9.41 9.54 9.78
Debt Growth
36.66 27.10 -40.80 8.10 14.27 2.33 -40.08 15.53 5.18 -10.54 33.80 -1.99 15.69 1.47 -1.23
Liquidity
Current Ratio
352.72 200.10 303.59 244.53 310.17 330.65 373.83 385.06 330.09 328.61 153.32 232.79 222.42 203.01 261.14
Quick Ratio
274.98 114.11 238.81 173.53 223.10 242.94 264.60 308.58 269.36 258.16 111.15 168.98 160.83 132.08 179.73
Cash Ratio
220.75 85.92 192.00 124.19 166.98 183.40 203.14 242.48 212.03 191.89 66.44 98.23 86.89 56.58 99.19
Operating Cash Flow Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - 100
Turnover
Inventory Turnover
396.56 351.12 343.65 320.91 304.60 316.05 369.13 376.17 358.78 349.06 347.28 347.50 350.84 301.16 326.67
Receivables Turnover
753.11 626.47 769.19 743.01 754.39 710.17 666.34 673.40 617.68 633.25 555.16 514.36 539.16 487.40 529.28
Payables Turnover
713.03 503.81 653.81 705.86 751.62 713.26 715.77 780.16 676.39 655.00 666.10 706.78 652.92 538.97 805.74
Asset Turnover
58.87 56.45 73.04 65.09 63.47 64.88 54.01 53.75 53.05 57.53 54.62 55.46 59.03 65.12 63.49
Coverage
Interest Coverage
53.41 589.58 1,245.35 1,107.92 888.79 735.40 790.91 854.17 1,064.56 1,237.33 1,271.62 1,084.62 1,662.96 1,926.19 1,421.05
Asset Coverage
200 200 300 300 300 300 300 300 300 300 200 300 200 200 300
Cash Flow Coverage (CFGR)
13.17 19.29 57.67 51.99 42.68 26.30 29.49 41.50 44.21 60.42 42.42 39.04 53.40 47.38 63.72
EBITDA Coverage
200 800 1,500 1,400 1,200 1,000 1,200 1,100 1,300 1,600 1,600 1,500 2,100 2,200 1,700
Dividend Coverage
- - - - - - -1,100 -400 -200 -200 -300 -400 -100 -500 -300 -500 -500 -400
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
Market Prospects
Dividend Yield
- - - - - - 1.16 1.26 1.34 1.06 1.06 0.78 0.92 0.87 0.70 0.49 0.60 0.87
Earnings Yield
-0.51 7.24 11.00 12.87 5.85 3.78 3.17 3.24 3.12 1.52 4.50 2.28 2.53 3.03 4.08
Price/Earnings (P/E)
-19,744.32 1,381.88 908.99 776.89 1,709.71 2,648.59 3,159.32 3,087.79 3,202.58 6,581.52 2,220.87 4,387.46 3,945.97 3,298.78 2,450.87
Price/Book (P/B)
244.24 271.50 213.53 172.86 234.17 249.12 302.63 334.92 453.91 455.39 500.96 647.36 885.99 782.13 519.94
Price/Sales (P/S)
136.59 158.39 139.06 130.61 182.52 188.56 311.39 338.03 489.84 423.23 460.69 590.86 755.60 604.07 444.76
Price/Cash Flow (P/CF)
1,500.18 1,211.09 730.08 729.44 1,074.51 1,846.21 2,560.91 1,791.15 2,464.08 1,913.30 2,329.63 3,425.17 3,215.24 3,152.95 1,715.06
End of A's Analysis
CIK: 1090872 CUSIP: 00846U101 ISIN: US00846U1016 LEI: - UEI: -
Secondary Listings
A has no secondary listings inside our databases.